FOCAL EPILEPSY
Researching an investigational treatment option for Focal Onset Epilepsy
FAQs
Approximately 390 people will participate in the Rise study.
The study will consist of an 8-week observation phase, followed by an 8 to 12-week double-blind treatment phase and possible 2-week follow up.
No. If you qualify and are chosen to participate, you will receive all study-related care at no cost to you. Insurance is not required and compensation for participation may be provided.
Like all Biohaven clinical studies, your participation is fully voluntary. You may leave the study at any time.
Fill out this form to See If You Qualify
4
Questions
1
Minute
Take our short self assessment.
In approximately a minute, you can see if you qualify for our study.
Your personal information and your answers to the study questions are only used for the purposes of determining if the clinical study is suitable for you. You can at any time withdraw your consent and have your personal data removed.